Drug
Indibulin
Indibulin is a pharmaceutical drug with 6 clinical trials. Historical success rate of 66.7%.
Total Trials
6
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 4 completed trials
Completion Rate
67%(4/6)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(33%)
Phase Distribution
Ph phase_1
6
100%
Phase Distribution
6
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution6 total trials
Phase 1Safety & dosage
6(100.0%)
Highest Phase Reached
Phase 1Trial Status & Enrollment
Completion Rate
66.7%
4 of 6 finished
Non-Completion Rate
33.3%
2 ended early
Currently Active
0
trials recruiting
Total Trials
6
all time
Status Distribution
Completed(4)
Terminated(2)
Detailed Status
Completed4
Terminated2
Development Timeline
Analytics
Development Status
Total Trials
6
Active
0
Success Rate
66.7%
Most Advanced
Phase 1
Trials by Phase
Phase 16 (100.0%)
Trials by Status
completed467%
terminated233%
Recent Activity
0 active trials
Showing 5 of 6
terminatedphase_1
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
NCT01113970
terminatedphase_1
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
NCT00726687
completedphase_1
Phase I Study in Advanced Solid Tumors
NCT00591292
completedphase_1
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
NCT00591383
completedphase_1
Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
NCT00591890
Clinical Trials (6)
Showing 6 of 6 trials
NCT01113970Phase 1
Study of a Novel Indibulin Dosing Schedule for the Treatment of Metastatic Breast Cancer
NCT00726687Phase 1
Phase 1b Study of Indibulin in Combination With Capecitabine in Advanced Solid Tumors
NCT00591292Phase 1
Phase I Study in Advanced Solid Tumors
NCT00591383Phase 1
Phase I Study of Indibulin in Combination With Erlotinib in Advanced Solid Tumors
NCT00591890Phase 1
Phase IB Study of Indibulin Using Positron-Emission Tomography (PET) Scans
NCT00591136Phase 1
Phase I Study of Indibulin in Patients With Solid Tumors
All 6 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 6